Bullock T - Search Results

1

Haemolytic transfusion reaction in a Gy(a-) patient with anti-Gy^a : a case report.

Dwight M, Bullock T, Dowling K, Ricks J, Jenner M, Boyce S, Narayanan S, Latham T. Dwight M, et al. Among authors: bullock t. Transfus Med. 2019 Jun;29(3):211-213. doi: 10.1111/tme.12583. Epub 2019 Feb 27. Transfus Med. 2019. PMID: 30811735 No abstract available.

2

Current topics in red cell biology: report on the Red Cell Special Interest Group meeting held at NHS Blood and Transplant Bristol on 30 October 2015.

Bullock T, Bruce LJ, Ridgwell K. Bullock T, et al. Transfus Med. 2016 Aug;26(4):241-5. doi: 10.1111/tme.12316. Epub 2016 May 25. Transfus Med. 2016. PMID: 27221954

3

Bombay phenotype (O_h ) and high-titer anti-H in pregnancy: two case reports and a review of the literature.

Bullock T, Win N, Jackson B, Sivarajan S, Penny J, Mir N. Bullock T, et al. Transfusion. 2018 Dec;58(12):2766-2772. doi: 10.1111/trf.14906. Epub 2018 Sep 27. Transfusion. 2018. PMID: 30260479 Review.

4

Use of thawed and washed red cells preserved in extended storage media for neonatal exchange transfusion.

Thomas MR, Bullock T, Kendall GS, Win N. Thomas MR, et al. Among authors: bullock t. Transfus Med. 2019 Apr;29(2):128-130. doi: 10.1111/tme.12574. Epub 2019 Jan 7. Transfus Med. 2019. PMID: 30618201 No abstract available.

5

Advances in Transfusion Medicine RCPath, November 2018.

Bullock T, Hazell M, McCullagh J. Bullock T, et al. Transfus Med. 2019 Feb;29(1):4-15. doi: 10.1111/tme.12590. Transfus Med. 2019. PMID: 30859639 No abstract available.

6

Prevention of hemolytic transfusion reactions with intravenous immunoglobulin prophylaxis in U- patients with anti-U.

Win N, Almusawy M, Fitzgerald L, Hannah G, Bullock T. Win N, et al. Among authors: bullock t. Transfusion. 2019 Jun;59(6):1916-1920. doi: 10.1111/trf.15230. Epub 2019 Mar 12. Transfusion. 2019. PMID: 30861151

7

Rejuvenation of RBCs: validation of a manufacturing method suitable for clinical use.

Smethurst PA, Jolley J, Braund R, Proffitt S, Lynes T, Hazell M, Mellor P, Ridgwell K, Procter S, Griffiths A, Marinaki AM, New HV, Murphy GJ, Edmondson D, Cardigan R; REDJUVENATE Trial Investigators. Smethurst PA, et al. Transfusion. 2019 Sep;59(9):2952-2963. doi: 10.1111/trf.15426. Epub 2019 Jul 11. Transfusion. 2019. PMID: 31294868

8

Two case reports involving therapeutic monoclonal anti-CD47 (Hu5F9-G4), it's effect on compatibility testing and subsequent selection of components for transfusion.

Reyland L, Dwight M, Bullock T, Latham T, Lord K, Wardle A, Palmer D, Eggington J, Callaghan T, Seals D, Kulkarni S. Reyland L, et al. Among authors: bullock t. Transfus Med. 2020 Apr;30(2):157-160. doi: 10.1111/tme.12664. Epub 2020 Jan 8. Transfus Med. 2020. PMID: 31914482 No abstract available.

9

Large red cell-derived membrane particles are major contributors to hypercoagulability in sickle cell disease.

Smith RA, Mankelow TJ, Drizou D, Bullock T, Latham T, Trompeter S, Blair A, Anstee DJ. Smith RA, et al. Among authors: bullock t. Sci Rep. 2021 May 26;11(1):11035. doi: 10.1038/s41598-021-90477-z. Sci Rep. 2021. PMID: 34040079 Free PMC article.

10

Alloimmunisation rate of patients on Daratumumab: A retrospective cohort study of patients in England.

Bullock T, Foster A, Clinkard B. Bullock T, et al. Transfus Med. 2021 Dec;31(6):474-480. doi: 10.1111/tme.12808. Epub 2021 Aug 17. Transfus Med. 2021. PMID: 34405478

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

339 results

Search Page

Filters